clinical trial · NCT07507422
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
Medtronic·—·not yet recruiting·n = 970
Chronic PainIntractable PainCommercially available Inceptiv™ neurostimulation systems
brief summary
The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
started
Apr 17, 2026
primary completion
Jun 27, 2029
completion
Jan 11, 2034
last updated
Apr 2, 2026
official title
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol